In this issue...
The work of the WBBA is dramatically extended by a network of business and scientific experts who are working to build a leading life sciences community globally. Committee descriptions are available online. Please e-mail the assigned staff member if you are interested in volunteering on one of our important committees:
Interested in volunteering at a WBBA's event? We typically need volunteers for Life Science Innovation Northwest and the Governor's Life Science Summit and Annual Meeting. Contact Cole Basque for more information.
Did you know...
you can update your subscriptions for email communications from WBBA?
1. Go to www.washbio.org and select Member Center, Edit Profile from the top navigation panel
While you're there, you can update your profile fields too!
Making your innovation our business.
Pro Bono Consulting
Chris Porter and Christiana DelloRusso are available to offer guidance and mentoring to WBBA member organizations. You can schedule a meeting with them by emailing email@example.com. The Commercialization Team’s focus for 2011 remains on access to capital and formalized investor relations both inside and outside of the state.
Event Review – SBIR Grants Roundtable Discussion
On May 24th, local SBIR grant gurus were invited to participate in a WBBA-organized discussion sponsored by WRF Capital. The goal of the Roundtable was to bring together successful grantees and support personnel to share information that will help bring more federal small business grant dollars to Washington state. The lively discussion highlighted three key points for SBIR applicants and new grantees:
More tips from the SBIR Roundtable discussion can be found in the Grants section of lifesciencestartup.com.
The second WBBA Venture Investment and Partnering (VIP) Forum of 2011 was held on April 20th with Johnson & Johnson’s Corporate Office of Science & Technology (COSAT), which provides non-dilutive funding to early stage life sciences and health technology companies. During these events, investors and strategic partners travel to Seattle for a customized day long schedule of one-on-one meetings with the region’s most promising life science companies, entrepreneurs, researchers and emerging companies.
Upcoming VIP Forums are scheduled with:
Merck Global Health Innovation Group
Bayer Healthcare Science Hub
Interested companies need to apply, and be WBBA members, to take advantage of this invaluable opportunity. More information and instructions on how to apply for VIP Forum are available on the WBBA website, or by emailing firstname.lastname@example.org. VIP Forums are made possible by the generous support of Cooley LLP and the Life Sciences Discovery Fund.
WINGS, The Washington Medical Technology Angel Network is a joint initiative of WBBA and the medical technology community. WINGS’s mission is to close the gap in early stage funding to accelerate the translation of medical technology innovation from the lab bench to patients. WINGS held its second Investor Meeting of 2011 with company presentations from Adaptive TCR, Cadence Biomedical and Nexgenia, as well as company updates from Cardiac Insight, Impel NeuroPharma and Emergent Detection.
WINGS looks forward to its remaining 2011 quarterly investor meetings on July 19 and October 18. Emerging medical technology companies are encouraged to apply to present. To be considered for the next round of screening, applications are due on September 13, 2011 for the October investor meeting. For more information on how to apply to present, to become a WINGS investor or to sponsor WINGS visit www.medtechwings.com or email email@example.com.
WINGS was recently profiled in the Puget Sound Business Journal. With 6 of the first 12 presenting companies receiving some WINGS and other investment, the WINGS Angel Network has established itself as a viable source of capital and business expertise for emerging medical device companies in Washington state.